Last reviewed · How we verify
NCT03684187
Mindfulness - Based Intervention in the Treatment of Fatigue in Patients With Primary Biliary Cholangitis
NA trial testing Mindfulness Based Intervention in Primary Biliary Cholangitis in 6 participants. Terminated before completion.
26 June 2019
Quick facts
| Lead sponsor | Yale University |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 6 |
| Start date | 19 November 2018 |
| Primary completion | 26 June 2019 |
| Estimated completion | 17 April 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Mindfulness Based Intervention
Conditions studied
- Primary Biliary Cholangitis — all drugs for Primary Biliary Cholangitis →
Sponsor
Yale University
Who can join
Adults 18 to 75, any sex, with Primary Biliary Cholangitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To assess the efficacy of mindfulness-based intervention (MBI) intervention in the treatment of moderate or severe fatigue in patients with primary biliary cholangitis (PBC).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Clinical Updates in Primary Biliary Cholangitis: Trends, Epidemiology, Diagnostics, and New Therapeutic Approaches.
Galoosian A, Hanlon C, Zhang J, Holt EW, et al · · 2020 · cited 33× · PMID 32274345 · DOI 10.14218/jcth.2019.00049
Verify or expand the search:
- PubMed search for NCT03684187
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Mindfulness Based Intervention
Trials testing the same drug.
- NCT07486505 — Mindfulness in Fracture Recovery and Reduction of Opioid Reliance: Evaluating the Feasibility of Implementing a Brief, M · NA · not yet recruiting
- NCT03972020 — Mindful-life: Mindfulness Based Intervention vs Cognitive Behavioral Therapy in Patients With Breast Cancer · NA · unknown
- NCT04632498 — Investigating Biological Markers, Targets, and Intervention for Mood Disorders · NA · terminated
- NCT04625504 — Investigating Biological Targets, Markers, and Intervention for Chronic Pain · NA · completed
- NCT04417153 — Who Benefits More? Optimising Mindfulness Based Interventions for Improved Psychological Outcomes · unknown
Other recruiting trials for Primary Biliary Cholangitis
Currently open trials in the same condition.
- NCT07449793 — Biochemical Response and Clinical Outcomes in Patients With PBC · recruiting
- NCT07282353 — A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA · Phase 3 · recruiting
- NCT06730061 — A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC) · Phase 3 · active not recruiting
- NCT06447168 — A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholang · recruiting
- NCT06427395 — Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis · Phase 3 · recruiting
Other Yale University trials
Trials by the same sponsor.
- NCT06900998 — Pilot Study: Effects of Nimodipine on Alcohol Drinking · Phase 2 · not yet recruiting
- NCT04910984 — Developing a Chatbot to Promote HIV Testing · NA · not yet recruiting
- NCT07458087 — Accuracy of the Accuro 3S · NA · not yet recruiting
- NCT07398404 — A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Pa · Phase 1, PHASE2 · not yet recruiting
- NCT07305324 — Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03684187 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yale University
- Last refreshed: 25 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03684187.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing